First in Oklahoma - CoreValve for Commercial Use, TAVR
On Friday, February 21, a team of Oklahoma Heart Institute physicians, led by Drs. Kamran Muhammad, Wayne Leimbach Jr. and Paul Kempe performed the first three successful commercial Transcatheter Aortic Valve Replacement (TAVR) procedures in Oklahoma using the recently FDA-approved Medtronic CoreValve.